Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7030
Source ID: NCT01511198
Associated Drug: Liraglutide
Title: Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: liraglutide|DRUG: metformin
Outcome Measures: Primary: Body weight | Secondary: FPG (fasting plasma glucose)|HbA1c (glycosylated haemoglobin)|Fructosamine|Lipids|Adverse events
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 223
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2001-02
Completion Date: 2001-10
Results First Posted:
Last Update Posted: 2017-01-26
Locations: Novo Nordisk Investigational Site, Vestavia, Alabama, 35209, United States|Novo Nordisk Investigational Site, Tucson, Arizona, 85719, United States|Novo Nordisk Investigational Site, Carlisle, Arkansas, 72024, United States|Novo Nordisk Investigational Site, Jonesboro, Arkansas, 72401, United States|Novo Nordisk Investigational Site, Alhambra, California, 91801, United States|Novo Nordisk Investigational Site, Mission Viejo, California, 92691, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Trumbull, Connecticut, 06611, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32216, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Miami, Florida, 33156, United States|Novo Nordisk Investigational Site, Ocala, Florida, 34471, United States|Novo Nordisk Investigational Site, Pembroke Pines, Florida, 33024, United States|Novo Nordisk Investigational Site, St. Petersburg, Florida, 33702, United States|Novo Nordisk Investigational Site, Titusville, Florida, 32796, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Springfield, Illinois, 62711, United States|Novo Nordisk Investigational Site, Worcester, Massachusetts, 01605, United States|Novo Nordisk Investigational Site, Duluth, Minnesota, 55805, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63117, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, North Plainfield, New Jersey, 07060, United States|Novo Nordisk Investigational Site, Charlotte, North Carolina, 28277, United States|Novo Nordisk Investigational Site, Durham, North Carolina, 27710, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73104, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37404, United States|Novo Nordisk Investigational Site, Corpus Christi, Texas, 78404, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78209, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Salt Lake City, Utah, 84132, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23294, United States|Novo Nordisk Investigational Site, Edmonds, Washington, 98026-7610, United States|Novo Nordisk Investigational Site, Edmonds, Washington, 98026, United States|Novo Nordisk Investigational Site, Renton, Washington, 98057, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States|Novo Nordisk Investigational Site, Charleston, West Virginia, 25301, United States
URL: https://clinicaltrials.gov/show/NCT01511198

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D089 Metformin small molecule DB00331 Details